Presentation TCT 2012 When Should the MitraClip Be Considered for Front-Line Therapy of Degenerative MR? Presenter: Michael Rinaldi October 23, 2012
Presentation TCT 2012 What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights Presenter: Patrick Serruys October 23, 2012
Presentation TCT 2012 The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results Presenter: Jonathon Leipsic October 23, 2012
Presentation TCT 2012 TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from... Presenter: Ricardo Costa October 23, 2012
Presentation TCT 2012 State-of-the-Field Keynote: Technical and Biological Challenges for Future DCB Development Presenter: Juan Granada October 23, 2012
Presentation TCT 2012 TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology Presenter: Rishi Puri October 23, 2012
Presentation TCT 2012 TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial Presenter: Gregg Stone October 23, 2012
Presentation TCT 2012 Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con! Presenter: Alex Powell October 23, 2012
Presentation TCT 2012 TCT-93. Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis Presenter: Sammy Elmariah October 23, 2012